91制片厂

0 items USD 0.00

Search

Did you mean: advanced therapeutics interaction

Your search for "advanced therapeutics intervention" gave back 7168 results.

Transient Receptor Potential Cation Channel Subfamily V Member 1 - Pipeline Review, H2 2019

Transient Receptor Potential Cation Channel Subfamily V Member 1 - Pipeline Review, H2 2019 Summary Transient Receptor Potential Cation Channel...

颁补迟补濒辞驳:听

Global Markets Direct

December 2019

Price: USD 3,500.00

Transient Receptor Potential Cation Channel Subfamily V Member 1 - Pipeline Review, H1 2020

Transient Receptor Potential Cation Channel Subfamily V Member 1 - Pipeline Review, H1 2020 Summary Transient Receptor Potential Cation Channel...

颁补迟补濒辞驳:听

Global Markets Direct

June 2020

Price: USD 3,500.00

Sarcopenia - Pipeline Review, H2 2019

Sarcopenia - Pipeline Review, H2 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Sarcopenia -...

颁补迟补濒辞驳:听

Global Markets Direct

November 2019

Price: USD 2,000.00

Sarcopenia - Pipeline Review, H1 2019

Sarcopenia - Pipeline Review, H1 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Sarcopenia -...

颁补迟补濒辞驳:听

Global Markets Direct

February 2019

Price: USD 2,000.00

Sarcopenia - Pipeline Review, H2 2018

Sarcopenia - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Sarcopenia -...

颁补迟补濒辞驳:听

Global Markets Direct

July 2018

Price: USD 2,000.00

Drug Overdose - Pipeline Review, H2 2018

Drug Overdose - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Drug...

颁补迟补濒辞驳:听

Global Markets Direct

September 2018

Price: USD 2,000.00

Transmembrane Prolyl 4 Hydroxylase (Hypoxia Inducible Factor Prolyl Hydroxylase 4 or P4HTM or EC 1.14.11.) - Pipeline Review, H2 2018

Transmembrane Prolyl 4 Hydroxylase (Hypoxia Inducible Factor Prolyl Hydroxylase 4 or P4HTM or EC 1.14.11.) - Pipeline Review, H2 2018 Summary...

颁补迟补濒辞驳:听

Global Markets Direct

September 2018

Price: USD 3,500.00

Atrial Fibrillation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Atrial Fibrillation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's...

颁补迟补濒辞驳:听

Global Markets Direct

March 2022

Price: USD 2,000.00

Transmembrane Prolyl 4 Hydroxylase (Hypoxia Inducible Factor Prolyl Hydroxylase 4 or P4HTM or EC 1.14.11.) - Pipeline Review, H1 2018

Transmembrane Prolyl 4 Hydroxylase (Hypoxia Inducible Factor Prolyl Hydroxylase 4 or P4HTM or EC 1.14.11.) - Pipeline Review, H1 2018 Summary...

颁补迟补濒辞驳:听

Global Markets Direct

March 2018

Price: USD 3,500.00

Low Back Pain - Pipeline Review, H1 2018

Low Back Pain - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Low Back...

颁补迟补濒辞驳:听

Global Markets Direct

April 2018

Price: USD 2,000.00

Systemic Mastocytosis - Pipeline Review, H1 2018

Systemic Mastocytosis - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...

颁补迟补濒辞驳:听

Global Markets Direct

May 2018

Price: USD 2,000.00

Pheochromocytoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Pheochromocytoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's...

颁补迟补濒辞驳:听

Global Markets Direct

August 2022

Price: USD 2,000.00

Proto Oncogene Tyrosine Protein Kinase Src (Proto Oncogene c Src or pp60c src or SRC or EC 2.7.10.2) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

Proto Oncogene Tyrosine Protein Kinase Src (Proto Oncogene c Src or pp60c src or SRC or EC 2.7.10.2) Development by Therapy Areas and Indications,...

颁补迟补濒辞驳:听

Global Markets Direct

March 2022

Price: USD 3,500.00

Pheochromocytoma - Pipeline Review, H2 2018

Pheochromocytoma - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...

颁补迟补濒辞驳:听

Global Markets Direct

October 2018

Price: USD 2,000.00

Basal Cell Carcinoma (Basal Cell Epithelioma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Basal Cell Carcinoma (Basal Cell Epithelioma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary...

颁补迟补濒辞驳:听

Global Markets Direct

August 2022

Price: USD 2,000.00

听

Clients Who Trust Us

Market Research Reports Inc. Customers

Need tailor made 91制片厂 solution? We can help you with that too.

About Us

At 91制片厂. we aim to make it easier for decision makers to find relevant information and locate right 91制片厂 reports which can save their time and assist in what they do best, i.e. take time-critical decisions.

We work with our associate Global 91制片厂 firms who are known leaders in their respective domains to obtain right 91制片厂 solution for our customer鈥檚 needs, be it custom research or syndicated research reports.

Contact Us

91制片厂
16192 Coastal Hwy
Lewes, DE 19958, USA

USA: +1-302-703-9904

India: +91-8762746600

marketresearchreports

info@marketresearchreports.com

Latest Blog Posts

Stay Connected

漏 Copyright 2010-2026 91制片厂.. All Rights Reserved. M Market Research Reports and the M Market Research Reports Logo are registered trademarks of 91制片厂.

Disclaimer: 91制片厂. has no affiliation to, and is not associated with any other website(s) or organization(s). We offer syndicated research reports (like country analysis, SWOT analysis, competitive intelligence, industry reports, company reports and market analysis & trends reports) and custom 91制片厂 from our website MarketResearchReports.com only.

If you are looking for a 91制片厂 solution for your research requirements, please begin your search using the search box on top of this page or use our chat system to speak to our 91制片厂 consultants or directly write to us.